Biểu đồ giá cổ phiếu ARGX
ARGX Dự đoán giá cổ phiếu
argenx SE
$865.38
0.04%
$0.34
Tính đến ngày hôm nay:Aug 10, 16:00:13 GMT-4
Quay lại
argenx SE (ARGX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$865.04
Giá mở cửa
$867.81
Phạm vi ngày
$862.32 - $887.54
Phạm vi 52 tuần
$631.47 - $953.58
Khối lượng
155.6K
Khối lượng trung bình
331.7K
Tỷ suất cổ tức
--
EPS (TTM)
26.26
Vốn hóa thị trường
$53.8B
argenx SE là gì?
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
